P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,455.00
+60.00 (2.51%)
At close: Jan 29, 2026
16.90%
Market Cap70.90B
Revenue (ttm)22.13B +25.2%
Net Income6.65B -1.7%
EPS230.14 -0.3%
Shares Out28.88M
PE Ratio10.67
Forward PEn/a
Dividend40.00 (1.63%)
Ex-Dividend DateDec 29, 2025
Volume64,559
Average Volume46,955
Open2,395.00
Previous Close2,395.00
Day's Range2,375.00 - 2,460.00
52-Week Range1,974.00 - 3,300.00
Beta0.77
RSI46.53
Earnings DateFeb 27, 2026

About P&K Skin Research Center

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro clinical tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded i... [Read more]

Industry Commercial Physical and Biological Research
Founded 2010
Employees 99
Stock Exchange KOSDAQ
Ticker Symbol 347740
Full Company Profile

Financial Performance

In 2024, P&K Skin Research Center's revenue was 17.85 billion, an increase of 20.24% compared to the previous year's 14.84 billion. Earnings were 5.82 billion, an increase of 20.84%.

Financial Statements